v3.26.1
Summary of Significant Accounting Policies (Details)
¥ in Millions
6 Months Ended 12 Months Ended
Mar. 31, 2026
USD ($)
Segment
shares
Mar. 31, 2026
CNY (¥)
Segment
shares
Mar. 31, 2025
USD ($)
shares
Sep. 30, 2025
USD ($)
Mar. 31, 2026
CNY (¥)
Sep. 30, 2025
CNY (¥)
Sep. 30, 2024
USD ($)
Summary of Significant Accounting Policies [Line Items]              
Cash $ 72,485       ¥ 0.5    
Allowance for uncollectable balance amount 18,797     $ 18,214      
Inventory reserve 126,671     122,739     $ 124,512
Impairment loss of prepayments 503,044     487,428      
Investment amount 724,848     $ 702,346 ¥ 5.0 ¥ 5.0  
Investment income          
Research and development expenses 93,478   96,836        
Advertising expenses $ 1,912,566   1,248,783        
Number of reportable segment (in Segment) | Segment 1 1          
Number of operating segment (in Segment) | Segment 1 1          
Tax benefit percentage 50.00% 50.00%          
Penalties or interest relating to income taxes          
Significant income          
Percentage of vat rate 13.00% 13.00%          
Dilutive shares (in Shares) | shares        
Comprehensive income amount $ 438,872   $ 293,156        
Universe Pharmaceuticals Inc [Member]              
Summary of Significant Accounting Policies [Line Items]              
Ownership interest 20.00%       20.00%    
JX RCB Bank [Member]              
Summary of Significant Accounting Policies [Line Items]              
Ownership interest 5.00%       5.00%    
Investment amount $ 700,000 ¥ 5.0